The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. | The ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great ...

For people facing aggressive bladder cancer that no longer responds to standard treatment, options have often been grim—either undergo life-changing surgery to remove the bladder or try less effective ...

Cancer drugs that have been around for two decades were able to eliminate aggressive tumors in a "remarkable" clinical trial.

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...